Epstein Secrets

ximately 100 people at a farmhouse on the outskirts of La Cygnet' Also reporting are KOAM-TV Pittsburg, KS (11/13), KCTV-TV Kansas City, MO (11/13, Sloan, 133K), WIBW-TV Topeka, KS (11/13, Motter, 86K), KSNT-TV Topeka, KS (11/13, Witmer), and KSHB-TV Kansas City, MO (11/13, Palmer, 90K). Fourth Suspe

g maker to release an early analysis of vaccine trial data," could apply for the FDA's emergency authorization "as early as this week." BioNTech CEO Ugur Sahin: "If everything continues to go well, we will start to deliver the vaccine end of this year, beginning next year." However, Lopez added, "Supplying

ximately 100 people at a farmhouse on the outskirts of La Cygnet' Also reporting are KOAM-TV Pittsburg, KS (11/13), KCTV-TV Kansas City, MO (11/13, Sloan, 133K), WIBW-TV Topeka, KS (11/13, Motter, 86K), KSNT-TV Topeka, KS (11/13, Witmer), and KSHB-TV Kansas City, MO (11/13, Palmer, 90K). Fourth Suspe

g maker to release an early analysis of vaccine trial data," could apply for the FDA's emergency authorization "as early as this week." BioNTech CEO Ugur Sahin: "If everything continues to go well, we will start to deliver the vaccine end of this year, beginning next year." However, Lopez added, "Supplying

ximately 100 people at a farmhouse on the outskirts of La Cygne." Also reporting are KOAM-TV Pittsburg, KS (11/13), KCTV-TV Kansas City, MO (11/13, Sloan, 133K), WIBW-TV Topeka, KS (11/13, Motter, 86K), KSNT-TV Topeka, KS (11/13, Witmer), and KSHB-TV Kansas City, MO (11/13, Palmer, 90K). Fourth Suspe

g maker to release an early analysis of vaccine trial data," could apply for the FDA's emergency authorization "as early as this week." BioNTech CEO Ugur Sahin: "If everything continues to go well, we will start to deliver the vaccine end of this year, beginning next year." However, Lopez added, "Supplying